Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Journal of the Endocrine Society
|
February 8, 2024
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in <i>Ex Vivo</i> Cultured Rat Bones
Lilly Velentza, Malin Wickström, Per Kogner, et al.
Investigational New Drugs
|
October 9, 2007
The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro
Malin Wickström, Caroline Haglund, Henrik Lindman, et al.
Scientific Reports
|
May 17, 2023
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
Lilly Velentza, Malin Wickström, Per Kogner, et al.
Molecular Cancer Therapeutics
|
May 24, 2013
Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro
Xuping Wu, Linda Sooman, Malin Wickström, et al.
International Journal of Cancer
|
July 1, 2011
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo
Lova Segerström, Ninib Baryawno, Baldur Sveinbjörnsson, et al.
Journal of Natural Products
|
November 10, 2009
Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs
Jenny Felth, Linda Rickardson, Josefin Rosén, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatment
Emma Eriksson, Malin Wickström, Lova Segerström Perup, et al.
Journal of Drug Targeting
|
December 12, 2003
Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1
Joachim Gullbo, Malin Wickström, Marcus Tullberg, et al.
Biochemical Pharmacology
|
October 10, 2006
Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients
Malin Wickström, Katarina Danielsson, Linda Rickardson, et al.
Anticancer Research
|
January 2, 2020
Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines
Stefan Holzhauser, Monika Lukoseviciute, Teodora Andonova, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Journal of the Endocrine Society
|
February 8, 2024
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in <i>Ex Vivo</i> Cultured Rat Bones
Lilly Velentza, Malin Wickström, Per Kogner, et al.
Investigational New Drugs
|
October 9, 2007
The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro
Malin Wickström, Caroline Haglund, Henrik Lindman, et al.
Scientific Reports
|
May 17, 2023
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
Lilly Velentza, Malin Wickström, Per Kogner, et al.
Molecular Cancer Therapeutics
|
May 24, 2013
Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro
Xuping Wu, Linda Sooman, Malin Wickström, et al.
International Journal of Cancer
|
July 1, 2011
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo
Lova Segerström, Ninib Baryawno, Baldur Sveinbjörnsson, et al.
Journal of Natural Products
|
November 10, 2009
Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs
Jenny Felth, Linda Rickardson, Josefin Rosén, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatment
Emma Eriksson, Malin Wickström, Lova Segerström Perup, et al.
Journal of Drug Targeting
|
December 12, 2003
Activity of hydrolytic enzymes in tumour cells is a determinant for anti-tumour efficacy of the melphalan containing prodrug J1
Joachim Gullbo, Malin Wickström, Marcus Tullberg, et al.
Biochemical Pharmacology
|
October 10, 2006
Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients
Malin Wickström, Katarina Danielsson, Linda Rickardson, et al.
Anticancer Research
|
January 2, 2020
Targeting Fibroblast Growth Factor Receptor (FGFR) and Phosphoinositide 3-kinase (PI3K) Signaling Pathways in Medulloblastoma Cell Lines
Stefan Holzhauser, Monika Lukoseviciute, Teodora Andonova, et al.
Page
of 6